Conagra Brands Inc.: Form 10-Q for the period ended Feb 25, 2024
Filed with the SEC on Apr 4, 2024 and accepted by EDGAR at Apr 4, 2024, 20:30 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-02-25. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-11-27 to 2024-02-25 | $3.03bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2023-05-29 to 2024-02-25 | $9.14bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-11-27 to 2024-02-25 | $2.17bn | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2023-05-29 to 2024-02-25 | $6.62bn | us-gaap:CostOfGoodsAndServicesSold |
| Selling, general and administrative | 3 months2023-11-27 to 2024-02-25 | $387.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2023-05-29 to 2024-02-25 | $1.12bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-11-27 to 2024-02-25 | $578.4m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2023-05-29 to 2024-02-25 | $1.65bn | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2023-11-27 to 2024-02-25 | $95.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2023-05-29 to 2024-02-25 | $297.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-11-27 to 2024-02-25 | $308.6m | us-gaap:NetIncomeLoss |
| Net income | 9 months2023-05-29 to 2024-02-25 | $914.5m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-11-27 to 2024-02-25 | $0.64 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2023-05-29 to 2024-02-25 | $1.91 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-11-27 to 2024-02-25 | $0.64 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2023-05-29 to 2024-02-25 | $1.91 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-11-27 to 2024-02-25 | 480,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2023-05-29 to 2024-02-25 | 479,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2023-05-29 to 2024-02-25 | $1.53bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2023-05-29 to 2024-02-25 | $309.6m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2023-05-29 to 2024-02-25 | $492.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2023-05-29 to 2024-02-25 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-02-25 | $78.5m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-02-25 | $3.29bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-02-25 | $21.92bn | us-gaap:Assets |
| Current liabilities | At period end2024-02-25 | $3.47bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-02-25 | $12.69bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-02-25 | $8.51bn | us-gaap:LongTermDebt |
| Short-term borrowings | At period end2024-02-25 | $166.3m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-02-25 | $9.15bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2024-02-25 | 478,062,749 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001437749-24-011081. Last ingested by Listed: Oct 24, 2026, 14:51 ET. Listed shows no prices and gives no investment advice.